Glutamate-sensitive chemical exchange saturation transfer (CEST) MRI has been applied in the human brain and shows promise for detecting pathology related to dysfunctional glutamate regulation. Glutamate abnormalities are linked to cortical gray matter (GM) pathology and cognitive impairment in multiple sclerosis (MS), but quantitative assessment techniques are lacking. We optimized and applied CEST MRI at 7.0T in phantoms and in vivo to evaluate sensitivity to glutamate and the effect of saturation pulse duration. Our results show increased CEST contrast in cortical GM of MS patients relative to controls and demonstrate the potential of CEST in characterizing GM damage in MS.
This abstract and the presentation materials are available to members only; a login is required.